/Investor DB

Philips Ventures — Full Portfolio

9 tracked investments · listed companies and verified rows first

Babyscriptsbabyscripts.comin𝕏Nov 2021✓ verified

Babyscripts provides a maternity care platform with remote patient monitoring, risk screening, and care management services for pregnant and postpartum patients.

Digital HealthFemTechHealthtechSaaS

Juan Pablo Segura(Founder)inAnish Sebastian(Founder & CEO)in

Co-investorsCU Healthcare Innovation FundMemorialCare Innovation FundAAF Management Ltd.Builders + BackersCivilization Ventures Management, LlcIrishAngels+5 more

CVAidcvaidmedical.comFeb 2022

CVAid develops an AI-powered stroke triage platform using standard smartphones and mobile applications to enable early diagnosis, in-hospital process management, and post-discharge follow-up.

AI & Machine LearningDigital HealthMedical Devices

Co-investorsSanara Capital

DiA Imaging Analysisdia-analysis.comAug 2021Acquired

AI-based ultrasound analysis technology using machine learning to deliver fast and accurate clinical indications.

Co-investorsAgate Medical Investments LPMindset VentureConnecticut InnovationsDEFTA PartnersIsrael Innovation AuthorityOutlier Ventures+2 more

IOMEDiomed.healthinSep 2023

A health data platform aligned with European Health Data Space regulations that enables secondary use of clinical data from hospitals and healthcare providers.

AI & Machine LearningData & InfrastructureDigital HealthHealthtechBarcelona, ES

Gabriel Maeztuin

Co-investorsAdara VenturesEASO VenturesRedSeed VenturesXTX Markets

Moving Analyticsmovinganalytics.comin𝕏Jul 2022 · $20M

Movn Health is a healthcare company focused on improving access to cardiovascular care, working to improve health outcomes, care coordination, patient engagement, and retention.

Digital HealthHealthtechLos Angeles, US

Harshvardhan Vathsangam(Executive Officer, Director)Ade Adesanya(Co-Founder, President)inGaurav Sukhatme(Co-Founder)inHarsh Vathsangam, PhD(Co-Founder, CEO)inShuo Qiao(Co-Founder, Chief Technology & Compliance Officer)in

BoardBob Saunders(Director)in

Co-investorsAphelion CapitalFoothill VenturesSolve VenturesSteelSky VenturesWellington ManagementCiti Ventures+4 more

Noninvasix Medical Devicesnoninvasix.comin𝕏Feb 2021

Noninvasix develops a patented optoacoustic platform that non-invasively and continuously measures central venous oxygen saturation to help ICU clinicians diagnose and monitor tissue hypoxia in sepsis and septic shock patients in real time.

Digital HealthHardwareHealthtechMedical DevicesGalveston, US

Donald Prough(Clinical Vice President)inGraham L. Randall(Executive Officer, Director)David J. Giarracco(Chief Executive Officer)inThomas Luby(Director)Michael Lowe(Director)

Co-investorsGreen Park & Golf VenturesHealth WildcattersRockies Venture ClubTexas VenturesTMC Venture Fund

PreciseDxprecisedx.aiinJun 2025

PreciseDx develops molecular pathology diagnostic tools for cancer care, combining anatomical pathology with molecular and systems biology to enable precise diagnosis and treatment planning.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesNew York, US

Dr. Carlos Cordon-Cardo(Founder)Eric Converse(Chief Executive Officer and Director)inEdward Joseph Sitar(Chief Financial Officer)Wayne Brinster(Chief Executive Officer and Director)in

BoardErik Lium(Director)Westley Dupray(Director)

Co-investorsMerck Global Health Innovation FundMSD Global Health Innovation Fund

Xealthxealth.comin𝕏Sep 2021

Xealth offers an orchestration platform for Digital Care Execution that lets clinicians prescribe digital health programs directly from the EHR, coordinate care across patients and partners, and centralize engagement and outcome data.

Digital HealthHealthtechSaaSSeattle, US

Michael McSherry(Executive Officer, Director)Aaron Sheedy(Founder)inSundar Balasubramanian(Founder)William Bryant(Director)inEric Fu(Founder)Mike McSherry(Founder)

Co-investorsLRVHealthMemorialCare Innovation FundThreshold VenturesAtrium HealthDFJMcKesson Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Mytonomy

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.